Healthcare provider profile · identity verified

Sandhya R Dasari, MD

Internal Medicine · NASHUA, NH · NPI 1417929076

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	732	201
Omeprazole	Omeprazole	570	184
Amlodipine Besylate	Amlodipine Besylate	553	173
Levothyroxine Sodium	Levothyroxine Sodium	542	147
Rosuvastatin Calcium	Rosuvastatin Calcium	459	146
Lisinopril	Lisinopril	410	115
Gabapentin	Gabapentin	317	81
Metoprolol Succinate	Metoprolol Succinate	310	86
Losartan Potassium	Losartan Potassium	296	84
Pantoprazole Sodium	Pantoprazole Sodium	270	77
Albuterol Sulfate Hfa	Albuterol Sulfate	263	82
Lorazepam	Lorazepam	224	64
Metformin Hcl	Metformin Hcl	205	64
Famotidine	Famotidine	201	56
Alprazolam	Alprazolam	187	43
Metoprolol Tartrate	Metoprolol Tartrate	184	45
Simvastatin	Simvastatin	171	52
Hydrochlorothiazide	Hydrochlorothiazide	160	49
Duloxetine Hcl	Duloxetine Hcl	156	40
Citalopram Hbr	Citalopram Hydrobromide	154	44
Sertraline Hcl	Sertraline Hcl	149	45
Furosemide	Furosemide	141	48
Trazodone Hcl	Trazodone Hcl	131	40
Atenolol	Atenolol	123	35
Fluticasone Propionate	Fluticasone Propionate	121	38
Montelukast Sodium	Montelukast Sodium	102	27
Tizanidine Hcl	Tizanidine Hcl	101	24
Valsartan	Valsartan	100	31
Zolpidem Tartrate	Zolpidem Tartrate	95	23
Tramadol Hcl	Tramadol Hcl	89	19
Oxycodone Hcl	Oxycodone Hcl	85	13
Buspirone Hcl	Buspirone Hcl	83	25
Tamsulosin Hcl	Tamsulosin Hcl	79	20
Pravastatin Sodium	Pravastatin Sodium	78	25
Mirtazapine	Mirtazapine	76	22
Breo Ellipta	Fluticasone/Vilanterol	75	21
Eliquis	Apixaban	75	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	12
Fluoxetine Hcl	Fluoxetine Hcl	69	23
Venlafaxine Hcl Er	Venlafaxine Hcl	68	19
Spironolactone	Spironolactone	67	20
Clopidogrel	Clopidogrel Bisulfate	64	21
Bupropion Xl	Bupropion Hcl	62	19
Paroxetine Hcl	Paroxetine Hcl	62	11
Allopurinol	Allopurinol	56	16
Pregabalin	Pregabalin	56	13
Synthroid	Levothyroxine Sodium	56	18
Carvedilol	Carvedilol	55	15
Meloxicam	Meloxicam	54	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	53	18
Ezetimibe	Ezetimibe	52	17
Bupropion Hcl Sr	Bupropion Hcl	50	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	20
Cephalexin	Cephalexin	49	35
Glipizide Er	Glipizide	47	14
Warfarin Sodium	Warfarin Sodium	47	19
Escitalopram Oxalate	Escitalopram Oxalate	44	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	14
Prednisone	Prednisone	44	38
Sumatriptan Succinate	Sumatriptan Succinate	43	suppressed
Xarelto	Rivaroxaban	43	suppressed
Repatha Sureclick	Evolocumab	39	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	38	suppressed
Ondansetron Odt	Ondansetron	38	suppressed
Potassium Chloride	Potassium Chloride	38	suppressed
Amoxicillin	Amoxicillin	37	22
Valacyclovir	Valacyclovir Hcl	37	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	11
Wixela Inhub	Fluticasone Propion/Salmeterol	34	suppressed
Donepezil Hcl	Donepezil Hcl	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Metformin Hcl Er	Metformin Hcl	32	12
Nabumetone	Nabumetone	32	suppressed
Azithromycin	Azithromycin	31	26
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	31	11
Irbesartan	Irbesartan	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	20
Diazepam	Diazepam	29	suppressed
Torsemide	Torsemide	29	11
Advair Hfa	Fluticasone Propion/Salmeterol	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	26	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Ibuprofen	Ibuprofen	26	suppressed
Jardiance	Empagliflozin	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Glimepiride	Glimepiride	25	suppressed
Lidocaine	Lidocaine	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Lactulose	Lactulose	24	suppressed
Sucralfate	Sucralfate	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	16
Meclizine Hcl	Meclizine Hcl	22	15
Nystatin	Nystatin	22	12
Celecoxib	Celecoxib	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Methylprednisolone	Methylprednisolone	21	20
Trulicity	Dulaglutide	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Memantine Hcl	Memantine Hcl	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Fluconazole	Fluconazole	18	14
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	17
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Ramipril	Ramipril	17	suppressed
Baclofen	Baclofen	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Finasteride	Finasteride	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Topiramate	Topiramate	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Repatha Syringe	Evolocumab	13	suppressed
Cilostazol	Cilostazol	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Pulmicort Flexhaler	Budesonide	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Zioptan	Tafluprost/Pf	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error